PartsTable
Technical Data Sheet
2D5613Q ✓ Verified by PartsTable
· COMPONENT
WHAT YOU NEED TO KNOW
Verify manufacturer and server generation compatibility Check if Option PN or Spare PN — same part, different channel
Confirm exact part number — similar PNs may be different parts
PRODUCT OVERVIEW

The MANNITOL INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAVENOUS, special_features: 10% W/V MANNITOL ACTIVE INGREDIENT; WITH DILUENT; 500 ML PLASTIC BAGS; PACKAGE OF 24, primary_container_type: BAG, PLASTIC, protective_storage_feature: CONTROLLED ROOM TEMPERATURE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 24. This product is currently in active production with full OEM support.

This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-600-2642, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
2D5613Q
NSN: 6505-01-600-2642
FSC: 6505
CAGE: 04687 — BAXTER HEALTHCARE CORP IV SYSTEMS/GOV SALES (USA)
SPECIFICATIONS
administrationINTRAVENOUS
special_features10% W/V MANNITOL ACTIVE INGREDIENT; WITH DILUENT; 500 ML PLASTIC BAGS; PACKAGE OF 24
primary_container_typeBAG, PLASTIC
protective_storage_featureCONTROLLED ROOM TEMPERATURE
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity24
primary_container_content_quantity500.0 MILLILITERS
active_medicament_medicinal_strength10.0 PERCENTAGE, W/V MANNITOL ACTIVE INGREDIENT
part_name_assigned_by_controlling_agencyMANNITOL INJECTION USP 24S
NSN6505-01-600-2642
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available MANNITOL INJECTION TITLE COMPONENT PN 2D5613Q MFR MANNITOL INJECTION
KEY FEATURES
PRIMARY CONTAINER CONTENT QUANTITY: 500.0 MILLILITERS
ADMINISTRATION: INTRAVENOUS
TOTAL PRIMARY CONTAINER QUANTITY: 24
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 10.0 PERCENTAGE, W/V MANNITOL ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURE: CONTROLLED ROOM TEMPERATURE
PRIMARY CONTAINER TYPE: BAG, PLASTIC
TECHNICAL CHARACTERISTICS (FLIS)
PART NAME ASSIGNED BY CONTROLLING AGENCYMANNITOL INJECTION USP 24S
PRIMARY CONTAINER CONTENT QUANTITY500.0 MILLILITERS
ADMINISTRATIONINTRAVENOUS
SPECIAL FEATURES10% W/V MANNITOL ACTIVE INGREDIENT; WITH DILUENT; 500 ML PLASTIC BAGS; PACKAGE OF 24
TOTAL PRIMARY CONTAINER QUANTITY24
ACTIVE MEDICAMENT MEDICINAL STRENGTH10.0 PERCENTAGE, W/V MANNITOL ACTIVE INGREDIENT
PROTECTIVE STORAGE FEATURECONTROLLED ROOM TEMPERATURE
PRIMARY CONTAINER TYPEBAG, PLASTIC
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
VERIFIED SUBSTITUTES & CROSS-REFERENCES 8
27363Interchangeable
interchangeable cross-reference
interchangeable
D27363Interchangeable
interchangeable cross-reference
interchangeable
BD2E-35Interchangeable
interchangeable cross-reference
interchangeable
150B24002Interchangeable
interchangeable cross-reference
interchangeable
2D5613Interchangeable
interchangeable cross-reference
interchangeable
OSMITROL VIAFLEXInterchangeable
interchangeable cross-reference
interchangeable
LIFECYCLE
StatusACTIVE
AvailabilityOEM and secondary market
RoHS CompliantEAR99Not HAZMAT
Ready to buy 2D5613Q?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 2D5613Q?
2D5613Q is a MANNITOL INJECTION.
What parts can replace 2D5613Q?
There are 8 known substitutes for 2D5613Q: 27363, D27363, BD2E-35 and 5 more. Substitute compatibility should be verified for your specific system.
What is the NSN for 2D5613Q?
2D5613Q is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-600-2642. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Comments (0)
No comments yet. Be the first to share what you know.
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 2D5613Q